跳至主要内容
临床试验/NCT00721461
NCT00721461已完成1 期

Probe Study of the Tolerability of an Investigational Electroporation Device, MedPulser (Trademark) DNA Delivery System (DDS) in Healthy Adults 18 to 35 Years of Age

Merck Sharp & Dohme LLC0 个研究点目标入组 24 人开始时间: 2005年7月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
24
主要终点
Assess the tolerability of the MedPulser DDS device.

研究概览

简要总结

A study to evaluate the tolerability of electrostimulation applications with an investigational device known as the MedPulser DDS.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Must be between the ages of 18 and 35
  • •Woman who are able to become pregnant must use an acceptable form of birth control

排除标准

  • •You are breast feeding
  • •You have taken any type of pain reliever within 12 hours of electrostimulation
  • •You have participated in another clinical study within 4 weeks of starting this study or plan to participate in another clinical study while participating in this study
  • •You have muscle atrophy, weakness or neuromuscular disorder

研究组 & 干预措施

1

Experimental

V930

干预措施: V930 (Biological)

结局指标

主要结局

Assess the tolerability of the MedPulser DDS device.

时间窗: Severity of pain will be measured at time of treatment and 1, 5, 10, and 20 minutes and 24 hours after electrostimulation.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验